Aduro Biotech Inc (NASDAQ:ADRO)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ADRO

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ADRO

  • Market Cap$196.970m
  • SymbolNASDAQ:ADRO
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS00739L1017

Company Profile

Aduro Biotech Inc is a immunotherapy company focused on the discovery, development and commercialization of therapies that are designed to harness the body's natural immune system for the treatment of patients with challenging diseases. Its primary technologies related are to the Stimulator of Interferon Genes (STING) and A Proliferation Inducing Ligand. The STING pathway activator technology is designed to activate the intracellular STING receptor. The APRIL is a soluble factor that binds to BCMA and TACI receptors thereby inducing signaling, and is implicated in IgA nephropathy.Aduro Biotech Inc is a clinical-stage biotechnology company focused on the discovery, development and commercialization of therapies that transform the treatment of different diseases.

Latest ADRO news

Currently there for this company. Visit our news hub for other news .